| The ACTA2 | Actin Alpha 2 (Smooth Muscle) gene (α-smooth muscle actin marker) |
| Arg-1 | Arginase-1 |
| AV | Atrioventricular valves |
| BAV | Bicuspid Aortic Valve |
| BHV | Bioprosthetic Heart Valve |
| BPM | Beats Per Minute |
| BP | Bisphosphonate |
| CC BY | Creative Commons Attribution license |
| CD86 | Cluster of Differentiation 86 |
| CD206 | Cluster of Differentiation 206 |
| ChsMA | Chitosan Methacryloyl (or Chitosan Methacrylate) |
| CNP | C-type Natriuretic Peptide |
| COL-I | Collagen Type I |
| COL-III | Collagen Type III |
| CS | Chondroitin Sulphate |
| Cu | Copper ions |
| CY-09 | CY-09 (NLRP3 inhibitor) |
| DAV | Decellularized Aortic Valve |
| DAVs | Decellularized Aortic Valves |
| DAPI | 4′,6-diamidino-2-phenylindole |
| DPP | Decellularized Porcine Pericardium |
| DPHV | Decellularized Porcine Heart Valve |
| DPVs | Decellularized Porcine Valves |
| DTEHV | Decellularized Tissue-Engineered Heart Valve |
| ECM | Extracellular Matrix |
| EPC | Endothelial Progenitor Cell(s) |
| FEA | Finite Element Analysis |
| FGF-2 | Fibroblast Growth Factor 2 |
| FRJS | Focused Rotary Jet Spinning |
| GAG | Glycosaminoglycans |
| GDF11 | Growth Differentiation Factor 11 |
| GelMA | Gelatin Methacrylate |
| GenAI | Generative Artificial Intelligence |
| HA | Hyaluronic Acid |
| HUVECs | Human Umbilical Vein Endothelial Cells |
| iMSCs | induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells |
| iNOS | inducible Nitric Oxide Synthase |
| iPSC | induced Pluripotent Stem Cell(s) |
| ISO | International Organization for Standardization |
| M1 | Pro-inflammatory macrophage phenotype (M1-like) |
| M2 | Reparative/pro-regenerative macrophage phenotype (M2-like) |
| MCP-1 | Monocyte Chemoattractant Protein-1 |
| MEW | Melt Electrowriting |
| MMPs | Matrix Metalloproteinases |
| MRI | Magnetic Resonance Imaging |
| MSCs | Mesenchymal Stem Cells |
| MSNs | Mesoporous Silica Nanoparticles |
| MSNPs | Mesoporous Silica Nanoparticles |
| MVP | Mitral Valve Prolapse |
| N/A | Not Applicable/Not Available |
| NiTi | Nitinol (Nickel–Titanium alloy) |
| NLRP3 | NLR family pyrin domain containing 3 |
| NO | Nitric Oxide |
| P4HB | Poly(4-hydroxybutyrate) |
| PCL | Poly(ε-caprolactone) |
| PEGDA | Poly(ethylene glycol) diacrylate |
| PET | Polyethylene terephthalate |
| PGA | Polyglycolic Acid |
| PGS | Poly(glycerol sebacate) |
| PHV | Polymeric Heart Valve |
| PIV | Particle Image Velocimetry |
| PLA | Polylactic Acid |
| PLCL | Poly(L-lactide-co-ε-caprolactone) |
| PLLA | Poly-L-lactic Acid |
| PTEN | Phosphatase and Tensin Homolog |
| PU | Polyurethane |
| PVA | Polyvinyl Alcohol |
| REDV | Arginine–Glutamic acid–Aspartic acid–Valine peptide sequence |
| RGD | Arginine–Glycine–Aspartic acid peptide motif |
| ROS | Reactive Oxygen Species |
| RSS | Reynolds Shear Stress |
| RVOT | Right Ventricular Outflow Tract |
| SDF-1α | Stromal cell-Derived Factor 1 alpha |
| SEM | Scanning Electron Microscopy |
| SF-PBA | Silk Fibroin–Phenylboronic Acid |
| siRNA | Small interfering RNA |
| SLs | Semilunar valves |
| SVs | Semilunar valves |
| SVD | Structural Valve Deterioration |
| TE | Tissue Engineering |
| TEHV | Tissue-Engineered Heart Valve |
| TEHVs | Tissue-Engineered Heart Valves |
| TGF-β | Transforming Growth Factor beta |
| TIMP | Tissue Inhibitor of Metalloproteinase |
| TIMPs | Tissue Inhibitors of Metalloproteinases |
| TKE | Turbulent Kinetic Energy |
| TPA-PVA | TPA–PVA hydrogel |
| UHMWPE | Ultra-high molecular weight polyethylene |
| VE-cadherin | Vascular Endothelial cadherin |
| VECs | Valve Endothelial Cells |
| VEGF | Vascular Endothelial Growth Factor |
| VHD | Valvular Heart Disease |
| VICs | Valvular Interstitial Cells |
| VSS | Wall Shear Stress |